-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The reporter learned from the Management Committee of Yantai Development Zone on the 10th that China's first original antibody-conjugated drug (ADC) new drug-vedicitumumab, declared by Rongchang Biopharmaceutical (Yantai) Co.
, Ltd.
, was approved by the China Food and Drug Administration Listing approval
.
Stomach cancer is the second largest cancer in China, with approximately 470,000 new patients in 2020
The reporter learned from the Management Committee of Yantai Development Zone on the 10th that China's first original antibody-conjugated drug (ADC) new drug-vedicitumumab, declared by Rongchang Biopharmaceutical (Yantai) Co.
, Ltd.
, was approved by the China Food and Drug Administration Listing approval